Evidence map›Paper›PMID 31400012›Full record

ArticleClinical endocrinology2019

Changes in subtypes of overt thyrotoxicosis and hypothyroidism following iodine fortification.

Mads Petersen, Inge Bülow Pedersen, Nils Knudsen, Stig Andersen, Torben Jørgensen, Hans Perrild, Lars Ovesen, Lone Banke Rasmussen, Betina H Thuesen, Allan Carlé

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Clinical endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Trace elements and the thyroid.Frontiers in endocrinology · 2022
    Review
  11. Iodine nutrition optimization: are there risks for thyroid autoimmunity?Journal of endocrinological investigation · 2021
    Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Mads PetersenDepartment of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.ORCID 0000-0002-1238-7850
Inge Bülow PedersenDepartment of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.
Nils KnudsenDepartment of Endocrinology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Stig AndersenDepartment of Geriatrics, Aalborg University Hospital, Aalborg, Denmark.
Torben JørgensenCentre for Clinical Research and Prevention, Bispebjerg/Frederiksberg Hospital, Copenhagen, Denmark.
Hans PerrildDepartment of Endocrinology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Lars OvesenDepartment of Gastroenterology, Slagelse Hospital, Slagelse, Denmark.
Lone Banke RasmussenDepartment of Endocrinology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Betina H ThuesenCentre for Clinical Research and Prevention, Bispebjerg/Frederiksberg Hospital, Copenhagen, Denmark.
Allan CarléDepartment of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.
Aalborg University Hospital · DKUniversity of Copenhagen · DKFrederiksberg Hospital · DKSlagelse Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the impact of mandatory iodine fortification (IF) on the incidence of nosological subtypes of overt thyrotoxicosis and hypothyroidism.

designWe identified and scrutinized all possible new cases of overt thyrotoxicosis and hypothyroidism in an open cohort in Northern Jutland (n = 309 434; 1 January 1997) during the years 2014-2016. Individual medical history was evaluated to verify and detail the incidence of overt thyroid dysfunction and for classification into nosological subtypes. A number of cases were excluded during final verification due to spontaneous normalization of thyroid function, as they had no medical history suggesting a known condition, which could transiently affect thyroid function (subacute/silent thyroiditis, PPTD and iatrogenic thyroid dysfunction). An identical survey was conducted in 1997-2000 prior to mandatory IF of salt (13 µg/g) that was in effect from year 2001.

resultsThe standardized incidence rate (SIR) of verified overt thyrotoxicosis decreased markedly from 97.5/100 000/year in 1997-2000 to 48.8 in 2014-2016 (SIRR: 0.50 [95% CI: 0.45-0.56]). This was due to a distinct decrease in the SIR of multinodular toxic goitre (SIRR: 0.18 [0.15-0.23]), solitary toxic adenoma (SIRR: 0.26 [0.16-0.43]) and to a lesser degree Graves' disease (SIRR: 0.67 [0.56-0.79]). SIR for overt hypothyroidism was unaltered by 2014-2016 (SIRR: 1.03 [0.87-1.22]). However, age distribution shifted with more young and fewer elderly cases of verified overt hypothyroidism.

conclusionMandatory IF caused a substantial reduction in SIR of verified overt thyrotoxicosis (especially of nodular origin) while avoiding an increase in SIR of verified overt hypothyroidism.

Indexed as

AdultFemaleHumansHypothyroidismIncidenceIodineMaleMiddle AgedReactive Oxygen SpeciesSodium Chloride, DietaryThyroid Function TestsThyrotoxicosisIodineReactive Oxygen SpeciesSodium Chloride, Dietaryepidemiologyhyperthyroidismhypothyroidismincidenceiodinemyxoedemathyrotoxicosis

Identifiers

PMID31400012
OpenAlexW2968043977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.